Literature DB >> 18386809

Disruption of chromodomain helicase DNA binding protein 2 (CHD2) causes scoliosis.

Shashikant Kulkarni1, Prabakaran Nagarajan, Jonathan Wall, Diana J Donovan, Robert L Donell, Azra H Ligon, Sundaresan Venkatachalam, Bradley J Quade.   

Abstract

Herein we characterize an apparently balanced de novo translocation, t(X;15)(p22.2;q26.1)dn, in a female patient with scoliosis, hirsutism, learning problems, and developmental delay (DGAP025). Other clinical findings include a high-arched palate, 2-3 syndactyly of the toes, and mildly elevated serum testosterone. No known or predicted genes are disrupted by the Xp22.2 breakpoint. The 15q26.1 breakpoint disrupts chromodomain helicase DNA binding protein 2 (CHD2). Another member of the chromatin-remodeling gene family, CHD7, has been associated with a defined constellation of congenital anomalies known as coloboma, heart anomaly, choanal atresia, mental retardation, genital and ear anomalies syndrome (CHARGE) and idiopathic scoliosis. Monosomy of 15q26 also has been associated with a spectrum of congenital abnormalities and growth retardation that overlaps with those of DGAP025. To provide a biological correlate, we characterized a mutant mouse model with Chd2 disruption that is associated with embryonic and perinatal lethality. Expression analysis indicated that Chd2 is expressed in the heart, forebrain, extremities, facial and dorsal regions during specific times of embryonic development. Chd2(+/m) mice showed pronounced lordokyphosis, reduced body fat, postnatal runting, and growth retardation. These data suggest that haploinsufficiency for CHD2 could result in a complex of abnormal human phenotypes that includes scoliosis and possibly features similar to CHARGE syndrome. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18386809      PMCID: PMC2834558          DOI: 10.1002/ajmg.a.32178

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  52 in total

1.  Mutations in a new member of the chromodomain gene family cause CHARGE syndrome.

Authors:  Lisenka E L M Vissers; Conny M A van Ravenswaaij; Ronald Admiraal; Jane A Hurst; Bert B A de Vries; Irene M Janssen; Walter A van der Vliet; Erik H L P G Huys; Pieter J de Jong; Ben C J Hamel; Eric F P M Schoenmakers; Han G Brunner; Joris A Veltman; Ad Geurts van Kessel
Journal:  Nat Genet       Date:  2004-08-08       Impact factor: 38.330

Review 2.  Mi-2/NuRD: multiple complexes for many purposes.

Authors:  Nathan J Bowen; Naoyuki Fujita; Masahiro Kajita; Paul A Wade
Journal:  Biochim Biophys Acta       Date:  2004-03-15

3.  Autism and multiple exostoses associated with an X;8 translocation occurring within the GRPR gene and 3' to the SDC2 gene.

Authors:  Y Ishikawa-Brush; J F Powell; P Bolton; A P Miller; F Francis; H F Willard; H Lehrach; A P Monaco
Journal:  Hum Mol Genet       Date:  1997-08       Impact factor: 6.150

4.  The association between Mi-2 antibodies and dermatomyositis.

Authors:  I N Targoff; M Reichlin
Journal:  Arthritis Rheum       Date:  1985-07

5.  Postnatal overgrowth by 15q-trisomy and intrauterine growth retardation by 15q-monosomy due to familial translocation t(13;15): dosage effect of IGF1R?

Authors:  Toshiro Nagai; Osamu Shimokawa; Naoki Harada; Satoru Sakazume; Hirofumi Ohashi; Naomichi Matsumoto; Kazuo Obata; Atsunori Yoshino; Nobuyuki Murakami; Takayasu Murai; Ryoichi Sakuta; Norio Niikawa
Journal:  Am J Med Genet       Date:  2002-11-22

6.  Deletion 15q24-26 in prenatally detected diaphragmatic hernia: increasing evidence of a candidate region for diaphragmatic development.

Authors:  D Schlembach; M Zenker; U Trautmann; R Ulmer; E Beinder
Journal:  Prenat Diagn       Date:  2001-04       Impact factor: 3.050

7.  Phenotypic delineation of ring chromosome 15 and Russell-Silver syndromes.

Authors:  G N Wilson; S E Sauder; M Bush; I Z Beitins
Journal:  J Med Genet       Date:  1985-06       Impact factor: 6.318

8.  SNTG1, the gene encoding gamma1-syntrophin: a candidate gene for idiopathic scoliosis.

Authors:  Stavros Bashiardes; Rose Veile; Missy Allen; Carol A Wise; Mathew Dobbs; Jose A Morcuende; Lazlos Szappanos; John A Herring; Anne M Bowcock; Michael Lovett
Journal:  Hum Genet       Date:  2004-04-16       Impact factor: 4.132

9.  Uterine leiomyomata with t(10;17) disrupt the histone acetyltransferase MORF.

Authors:  Steven D P Moore; Steven R Herrick; Tan A Ince; Michael S Kleinman; Paola Dal Cin; Cynthia C Morton; Bradley J Quade
Journal:  Cancer Res       Date:  2004-08-15       Impact factor: 12.701

10.  BayGenomics: a resource of insertional mutations in mouse embryonic stem cells.

Authors:  Doug Stryke; Michiko Kawamoto; Conrad C Huang; Susan J Johns; Leslie A King; Courtney A Harper; Elaine C Meng; Roy E Lee; Alice Yee; Larry L'Italien; Pao-Tien Chuang; Stephen G Young; William C Skarnes; Patricia C Babbitt; Thomas E Ferrin
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

View more
  30 in total

1.  De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome.

Authors:  Arvid Suls; Johanna A Jaehn; Angela Kecskés; Yvonne Weber; Sarah Weckhuysen; Dana C Craiu; Aleksandra Siekierska; Tania Djémié; Tatiana Afrikanova; Padhraig Gormley; Sarah von Spiczak; Gerhard Kluger; Catrinel M Iliescu; Tiina Talvik; Inga Talvik; Cihan Meral; Hande S Caglayan; Beatriz G Giraldez; José Serratosa; Johannes R Lemke; Dorota Hoffman-Zacharska; Elzbieta Szczepanik; Nina Barisic; Vladimir Komarek; Helle Hjalgrim; Rikke S Møller; Tarja Linnankivi; Petia Dimova; Pasquale Striano; Federico Zara; Carla Marini; Renzo Guerrini; Christel Depienne; Stéphanie Baulac; Gregor Kuhlenbäumer; Alexander D Crawford; Anna-Elina Lehesjoki; Peter A M de Witte; Aarno Palotie; Holger Lerche; Camila V Esguerra; Peter De Jonghe; Ingo Helbig
Journal:  Am J Hum Genet       Date:  2013-10-24       Impact factor: 11.025

Review 2.  Architects of the genome: CHD dysfunction in cancer, developmental disorders and neurological syndromes.

Authors:  Wangzhi Li; Alea A Mills
Journal:  Epigenomics       Date:  2014       Impact factor: 4.778

Review 3.  Chromodomain helicase DNA-binding proteins in stem cells and human developmental diseases.

Authors:  Joseph A Micucci; Ethan D Sperry; Donna M Martin
Journal:  Stem Cells Dev       Date:  2015-02-25       Impact factor: 3.272

4.  Four out of eight genes in a mouse chromosome 7 congenic donor region are candidate obesity genes.

Authors:  Kari A Sarahan; Janis S Fisler; Craig H Warden
Journal:  Physiol Genomics       Date:  2011-07-05       Impact factor: 3.107

Review 5.  The Chromodomain Helicase DNA-Binding Chromatin Remodelers: Family Traits that Protect from and Promote Cancer.

Authors:  Alea A Mills
Journal:  Cold Spring Harb Perspect Med       Date:  2017-04-03       Impact factor: 6.915

Review 6.  Genetics and genomics of autism spectrum disorder: embracing complexity.

Authors:  Silvia De Rubeis; Joseph D Buxbaum
Journal:  Hum Mol Genet       Date:  2015-07-17       Impact factor: 6.150

7.  Human CHD2 is a chromatin assembly ATPase regulated by its chromo- and DNA-binding domains.

Authors:  Jessica C Liu; Catarina G Ferreira; Timur Yusufzai
Journal:  J Biol Chem       Date:  2014-11-10       Impact factor: 5.157

8.  Autism-linked CHD gene expression patterns during development predict multi-organ disease phenotypes.

Authors:  Sahrunizam Kasah; Christopher Oddy; M Albert Basson
Journal:  J Anat       Date:  2018-10-02       Impact factor: 2.610

9.  A mutation in the mouse Chd2 chromatin remodeling enzyme results in a complex renal phenotype.

Authors:  Concetta G A Marfella; Nils Henninger; Scott E LeBlanc; Namrata Krishnan; David S Garlick; Lawrence B Holzman; Anthony N Imbalzano
Journal:  Kidney Blood Press Res       Date:  2009-01-14       Impact factor: 2.687

10.  Deletion of the Chd6 exon 12 affects motor coordination.

Authors:  Melissa J Lathrop; Lisa Chakrabarti; Jeremiah Eng; C Harker Rhodes; Thomas Lutz; Amelia Nieto; H Denny Liggitt; Sandra Warner; Jennifer Fields; Reinhard Stöger; Steven Fiering
Journal:  Mamm Genome       Date:  2010-01-29       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.